Daily Stock List
Matinas BioPharma Holdings, Inc. (MTNB)
Stock News reported recently on Matinas BioPharma Holdings, Inc. (MTNB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 2011, Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company with corporate headquarters in Bedminster, New Jersey. Its emphasis is on the development and commercialization of lipid-based prescription therapeutics for the treatment of infectious diseases and cardiovascular and metabolic conditions. An experienced management team and a Board of Directors with a history of building pharmaceutical companies lead Matinas. The Company’s shares trade on the OTC Markets Group’s OTCQB.
Matinas BioPharma’s focus is on creating highly differentiated, safe, and efficacious therapies employing its expertise in drug formulation and development to address important unmet medical needs. Recent additions to its product pipeline, including MAT2203 and MAT2501, position the Company to become a leader in the safe and effective delivery of anti-infective therapies using its proprietary lipid-crystal nano-particle cochleate formulations.
Last week, Matinas BioPharma Holdings announced that upon a scheduled interim review, the study's Steering Committee recommended to stop enrollment early in its first-in-human study of investigational drug MAT9001 because of the study having enrolled a sufficient number of subjects (42 to date) required to demonstrate primary and secondary endpoints.
Its first study is taking place in Canada and is a two-way crossover pharmacokinetic and pharmacodynamic (PK/PD) study of MAT9001 in comparison to an active prescription omega-3 medication comparator in subjects with high triglycerides (200-499 mg/dL). MAT9001 is a proprietary prescription-only omega-3 fatty acid-based composition, consisting of docosa-pentaenoic acid (DPA) and other omega-3 fatty acids, which is under development for therapeutic applications with severe hypertriglyceridemia (TG>500 mg/dL) as the lead indication.
In Q4 2014, Matinas BipPharma filed an IND for MAT9001 with the Food and Drug Administration (FDA). The Company anticipates initiating a Phase 3 registration program pending two small studies and FDA agreement on the Phase 3 protocol. Matinas has purposely designed MAT9001 to provide a differentiated pharmacotherapy for the treatment of dyslipidemia.
Matinas BioPharma Holdings, Inc. (MTNB), closed Monday's trading session at $0.70, up 7.69%, on 172,857 volume with 34 trades. The average volume for the last 60 days is 39,347 and the stock's 52-week low/high is $0.3101/$1.35.
PositiveID Corp. (PSID)
PennyStocks24, PennyStockInformer, OtcShortReport, SmallCapVoice, TheNextBigTrade, BestDamnPennyStocks, Penny Picks, Penny Stock Newsletter, PREPUMP STOCKS, and Damn Good Penny Picks reported recently on PositiveID Corp. (PSID), and today we report on the Company, here at the QualityStocks Daily Newsletter.
PositiveID Corp. is a developer of biological detection and diagnostics solutions. It is a developer of biological detection systems for the Unites States’ homeland defense industry and rapid biological testing. The Company’s concentration is on the development of microfluidic systems for the automated preparation of and performance of biological assays to detect biological threats at high-value locations and analyze samples in a medical environment. PositiveID has its corporate headquarters in Delray Beach, Florida.
PositiveID acquired MicroFluidic Systems (MFS) in May 2011. MFS specializes in the development and production of automated instruments for detecting and processing biological samples. Its core technology is used for airborne pathogen detection, rapid clinical diagnostics, and sample preparation applications.
Pertaining to Molecular Diagnostics, PositiveID’s products include M-BAND and Firefly. The Microfluidics-based Bioagent Networked Detector (M-BAND) developed by MFS is a bioaerosol monitor with fully integrated systems with sample collection, processing, as well as detection modules.
PositiveID is developing the Firefly Dx detection system. Firefly DX is its real-time, hand held, polymerase chain reaction (PCR) pathogen detection system. This system is a two-part device and it comprises a portable handheld instrument with wireless Bluetooth communication and disposable single-use cartridges containing all vital analytical elements.
PositiveID has reached a major milestone in the development of its handheld Firefly Dx system with the completion of the build of its breadboard PCR (polymerase chain reaction) chip. The Company announced last month that it successfully completed its first round of testing of its Phase II Firefly Dx prototype handheld real-time PCR pathogen detection system. It has delivered positive PCR results within 20 minutes. Its Firefly Dx testing was performed at standard laboratory volumes and attained equivalent results to laboratory-based PCR instruments that can take hours to perform the same PCR process.
The Company is developing Firefly Dx based on intellectual property (IP) and knowledge gained during years of development and $30 million of contract funding from the U.S. Department of Homeland Security for its M-BAND system. This system utilizes PCR for the identification of airborne bio-threats.
Last week, PositiveID announced that it successfully completed additional testing of its Phase II Firefly Dx prototype handheld, real-time PCR pathogen detection system. The Company detected multiple organisms with a multiplex assay designed to simultaneously test for up to four pathogens on the Firefly Dx PCR chip.
PositiveID Corp. (PSID), closed Monday's trading session at $0.0251, up 0.40%, on 8,805,543 volume with 465 trades. The average volume for the last 60 days is 2,973,280 and the stock's 52-week low/high is $0.021/$0.09.
Blue Calypso, Inc. (BCYP)
Ceocast News reported previously on Blue Calypso, Inc. (BCYP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Blue Calypso, Inc. develops digital innovation products and services for the social media marketplace utilizing its patented Intellectual Property (IP) portfolio. The Company enables businesses to employ digital advertising to share and socialize brand content and track performance, monitor engagements, and gather strong analytics – all at lower costs than traditional marketing. Blue Calypso is a digital word-of-mouth technology and marketing enterprise. Founded in 2009, Blue Calypso is based in Dallas, Texas.
The Company is a developer of patented mobile consumer engagement and social advocacy solutions for product manufacturers and retailers. Its technology solutions assist brands in engaging with their existing consumers to increase referrals. Blue Calypso licenses its IP, in addition to offering digital innovation services and solutions via Blue Calypso Labs (BC Labs). This includes DashTAGG®, SocialEcho™, and MobileADvantage™.
Blue Calypso Labs provides software development and consulting services to clients. Its aim is to help clients develop unique software solutions that solve strategic business problems, which take advantage of the Company’s portfolio of patented mobile social sharing technologies.
The Company’s Beacon technology solution is KIOSentrix™. It allows retailers to deliver content that is relevant based on their location. Blue Calypso’s SocialEcho™ is a patented social marketing technology. It assists companies in leveraging their existing advocates (customers, social media fans, and email subscribers) as brand ambassadors, sharing the brand’s content friend-to-friend, and trusted source to trusted source.
Blue Calypso’s MobileADvantage™ is a mobile-enabled point-of-purchase solution. It provides retailers with an innovative platform to deliver hyper-targeted, store-specific communication to customers.
Blue Calypso announced this past January that it filed a motion in the Eastern District of Texas to lift the negotiated stay on the pending patent infringement litigation between the Company and Groupon (GRPN), Yelp (YELP), Foursquare and IZEA.PK (IZEA) (the defendants). Additionally, Blue Calypso filed notices of appeal at the Federal Circuit Court of Appeals in each of the Covered Business Method Review (CBMR) cases at the Patent Trial and Appeals Board (PTAB).
Last week, Blue Calypso announced that the Court ruled to lift the stay on the pending patent infringement litigation in the Eastern District of Texas between the Company and Groupon (GRPN), Yelp (YELP), Foursquare and IZEA.PK (IZEA). A trial date has been set for December 14, 2015.
Recently, Blue Calypso reported Year End 2014 results. Revenue was up 122 percent in 2014 and up 692 percent when excluding 2013 settlement fees and licensing revenue. The Company attained an increase in Gross Profit of 75 percent over the prior year. Convertible Debentures were converted to common stock, therefore eliminating all debt. In addition, 28 claims across four patents were affirmed at PTAB.
Blue Calypso, Inc. (BCYP), closed Monday's trading session at $0.151, up 4.14%, on 225,950 volume with 32 trades. The average volume for the last 60 days is 85,252 and the stock's 52-week low/high is $0.07/$0.195.
Inergetics, Inc. (NRTI)
SmallCapVoice reported recently on Inergetics, Inc. (NRTI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Inergetics, Inc. is a leading developer of patented nutritional products consisting of high-quality ingredients and proprietary formulations. The Newark, New Jersey-based Company has targeted brands that independently serve the Clinical Nutrition, Long Term Care (Senior Care), and Sports Nutrition Markets. Inergetics has entered into a strategic partnership with Terra Tech Corp. (TRTC) to jointly develop a line of natural Cannibidiol based nutritional supplements. Terra Tech is an urban agricultural company.
Inergetics’ brand portfolio features Martha Stewart Essentials™. This is a complete line of whole-food based supplements created expressly for women, developed in association with Martha Stewart herself. Additionally, its brands include Bikini Ready®. Bikini Ready® is its comprehensive line of weight loss lifestyle products. Bikini Ready® products include Weight Loss Catalyst, Fashion Multi, Cleanse, and Yummy Shake Flavors, all specifically designed for women.
Inergetics also has its OmEssentials®. This is a line of scientifically advanced nutritional supplements designed to further the health and wellness of yoga practitioners and active individuals. The Company also offers SlimTrim™, which is an affordable, premium value diet brand. The formulation of SlimTrim™ is to work with one’s body naturally in combination with diet and exercise. The design of SlimTrim™ is to help one lose weight, burn fat, stimulate metabolism, cleanse, as well as curb appetite.
Furthermore, Inergetics’ brands include Surgex® Sports Nutrition, which is the preferred nutritional supplement of Army Sports. Its Surgex® Sports Nutrition is a clinically studied performance enhancing formula. The design of it is to build lean muscle and increase energy to realize top levels of power and stamina. Surgex® Sports Nutrition features novel formulas developed to meet the nutritional needs of the masses and amateur and professional athletes.
Last month, Inergetics announced the launch of Nulief™. This is a branded nutritional supplement offering the holistic benefits associated with Cannabidiol (CBD). Nulief™ is the first nutraceutical in a line of products undergoing development by Inergetics' new Whole Products® division to offer consumers the convenient benefits of non-psychoactive CBD.
Last week, Inergetics reported Preliminary Full Year 2014 results. On a preliminary basis for the year ended December 31, 2014, it expects total revenue generated from the sales of Surgex®, Bikini Ready®, SlimTrim, OmEssentials® and Martha Stewart™ Essentials to be $1,991,688. This reflects a greater than 135 percent increase over the $847,834 of total revenue reported during the prior year ended December 31, 2013. The Company expects gross profit to be $520,354, up 113 percent versus $244,830 in the prior year ended December 31, 2013.
Inergetics, Inc. (NRTI), closed Monday's trading session at $0.0146, up 8.96%, on 2,031,661 volume with 35 trades. The average volume for the last 60 days is 2,571,060 and the stock's 52-week low/high is $0.0082/$0.2499.
WeedHire International, Inc. (WDHR)
Pennybuster reported on WeedHire International, Inc. (WDHR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
WeedHire International, Inc. operates WeedHire.com. This is a career site specifically targeting employment within the legal cannabis industry. WeedHire.com launched in May 2014 as the premier marijuana jobs site for the legal cannabis industry. WeedHire is the central online portal and social media source for job seekers and providers. However, it is not involved with the growth, sale, or distribution of marijuana.
WeedHire International is based in Fair Lawn, New Jersey. The Company formerly went by the name AnythingIT, Inc. It changed its corporate name to WeedHire International, Inc. in November of 2014. WeedHire lists on the OTC Markets’ OTCQB.
The Company’s mission is to help its clients hire the most qualified individuals and to help those individuals find the best job opportunities in their respective fields, advancing their careers in legal marijuana. WeedHire.com provides job postings for cannabis jobs. These include recommending physicians, physician's assistants, growers, budtenders, dispensary operators, security guards, dispensary administrators, lighting specialists, delivery drivers, lab technicians, marketing specialists, lawyers, insurance agents, and government jobs.
Additionally, the specialized focus of WeedHire’s website benefits those job seekers through helping to ensure that the job opportunities posted by the Company’s customers are relevant and attractive to them. Moreover, WeedHire authors the Quarterly Cannabis Jobs Report. This Report quotes trends and statistics from the marijuana jobs market.
WeedHire International has signed an exclusive partnership with Hireology. Under the terms of the arrangement, WeedHire customers will have access to Hireology's award-winning collection of recruitment and selection technology. These include recruiting tools, pre-hire assessments, interview guides, skills testing, personality profiles, and background checks. Hireology is the leading provider of employee hiring and selection management technology.
Last week, WeedHire International announced that it released the first ever marijuana jobs app on Apple ITunes. The WeedHire ITunes cannabis job app now complements the Company’s release of the first ever Android App for Marijuana Jobs. The ITunes app can be downloaded by visiting www.weedhire.com.
WeedHire International, Inc. (WDHR), closed Monday's trading session at $0.0002, up 100.00%, on 115,170,769 volume with 58 trades. The average volume for the last 60 days is 95,721,610 and the stock's 52-week low/high is $0.0001/$0.09.
True Drinks, Inc. (TRUU)
SmallCapVoice reported recently on True Drinks, Inc. (TRUU), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed True Drinks, Inc. is a healthy beverage provider with major entertainment and media company licensing agreements for use of its characters on its proprietary, patented bottles. AquaBall™ Naturally Flavored Water is its vitamin-enhanced water. The Company created AquaBall™ as a healthy alternative for children to drink. AquaBall™ is now being sold into mass-market retailers across the United States. True Drinks is headquartered in Irvine, California.
AquaBall™ is a naturally flavored, vitamin-enhanced, zero-calorie, dye-free, sugar-free alternative to juice and soda. AquaBall™ contains no artificial colors or flavors. The product is enhanced with Vitamins B3, B5, B6, and B12 & C. In addition, AquaBall™ contains no high fructose corn syrup. It is sweetened with Stevia.
True Drinks’ target consumers are children, young adults, and their guardians, who are attracted to the product by the entertainment and media characters on the bottle. AquaBall™ is now available in four flavors. These are orange, grape, fruit punch and berry.
Regarding Energy Drinks, True Drinks has its Bazi All-Natural Energy drink with eight superfruits. Bazi All-Natural Energy is a 2-ounce blend of eight super-fruits, combined with D-Ribose. Bazi has no preservatives, lower calories, and naturally energizing antioxidants and powerful nutrients. Bazi contains 20 percent juice. Furthermore, True Drinks’ development team is pursuing additional beverage products, which will complement the Company’s current product lineup.
Recently, True Drinks announced that it entered into a strategic investment partnership with Vinny Smith's Toba Capital Management. Toba Capital Management has committed to a direct investment of $4.0 million into True Drinks. The Company has received the first $1.5 million. Vinny Smith, most notably recognized for selling his company Quest Software to Dell in 2012 for $2.4 billion, will provide added value to True Drinks as a strategic advisor.
Last week, True Drinks announced its financial results for the year ended December 31, 2014. Achievements for 2014 include it developing a club channel and packaging with new partner Sam's Club. True Drinks increased same store sales by 415 percent. It agreed to terms on the extension of the Disney licensing agreement through March 2017. Furthermore, the Company invested into incremental capacity allowing for a decrease in overall cost of goods.
True Drinks, Inc. (TRUU), closed Monday's trading session at $0.15, down 8.83%, on 404,920 volume with 46 trades. The average volume for the last 60 days is 199,686 and the stock's 52-week low/high is $0.1175/$0.489.
Yasheng Group (HERB)
Zacks reported previously on Yasheng Group (HERB), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Yasheng Group is a diversified agricultural conglomerate that lists on the OTC Markets Group’s OTCQB. Yasheng is a U.S. holding company, which conducts chiefly agricultural operations in the northwest of China. The Company designs, develops, manufactures and markets high-quality farming and sideline products including livestock and poultry. Yasheng Group is headquartered in Redwood City, California.
In addition, the Company designs, develops, and markets new technologies related to agriculture and genetic biology. It is one of China's foremost producers and marketers, with many major product segments. These include field crops, vegetables, fruit, specialty crops, hops, hemp, seeds, beef, and poultry.
Yasheng is a supplier of high-quality agricultural products to renowned conglomerates. The Company’s focus has been on acquiring an extensive amount of land long term for large scale industrial agro bases, with the needed natural resources to provide a long term infrastructure for people to work these basic ingredients to create high-end agriculture products. Yasheng produces greater than 51 major products in the northwest of China. Seven have received the national "Green Award" for meeting environmental and health quality standards.
The Company’s agriculture produce and by-products include Langfang poplars, peaches, and saplings, durum wheat (flower), cotton, cotton processing, corn seeds and processing, and dried fruit packages. It also includes garlic extract gels, feed materials, flowers, fruits, potato, hops extracts, pellet and compressed hops, Chinese TCM herbs, seeds, and many other agro products.
Yasheng is expanding its industrial hemp production in response to increasing global demand for this crop. The Company formed Hemp Route Ltd., a subsidiary created to manage the international distribution of its hemp products.
Yasheng Group entered into a Joint Venture (JV) agreement with Inner Mongolia Meng Yuan Agriculture Co. Ltd. The purpose of the JV is to create a new industrial hemp plantation and develop hemp products for domestic and export markets. The project is in the Bayinnaoer Region of Inner Mongolia. The first year expected planting area is approximately 5,000 acres; the second year is 10,000 acres, and the third year is 30,000 acres.
Yasheng Group is responsible for sales and marketing and providing seeds, seedlings, planting techniques, as well as fertilizer. Meng Yuan is responsible for the daily management of the crops. This includes pruning, watering, fertilization, and weeding.
Last month, Yasheng Group announced a hemp contract farming program for the Spring 2015 growing season. The establishment of the program is to allow customers to pre-order an assortment of hemp products including hulled seed, stalk, and fiber by the acre. The project is situated in the Bayinnaoer County Region of Inner Mongolia on 110,000 acres of agricultural land.
Yasheng Group (HERB), closed Monday's trading session at $0.694, up 8.44%, on 48,727 volume with 24 trades. The average volume for the last 60 days is 11,574 and the stock's 52-week low/high is $0.30/$1.40.
Start Scientific, Inc. (STSC)
The QualityStocks Daily Newsletter would like to spotlight Start Scientific, Inc. (STSC). Today, Start Scientific, Inc. closed trading at $0.03, up 42.86%, on 10,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 33,002, and its 52-week low/high is $0.01/$0.62.
Operating from headquarters in San Antonio, Texas, Start Scientific, Inc. (STSC) is in continual and aggressive pursuit of its corporate objective to take advantage of oil and gas exploration and development opportunities that are overlooked by mid-sized oil and gas companies.
Start Scientific’s is focused on developing leases and/or joint venture partnerships for its four primary projects in Mississippi, Texas, North Dakota and West Virginia. The projects include shallow, deep, and horizontal drilling opportunities. Geographically, the projects offer the company diversity for exploration and drilling.
As a progressive oil exploration, drilling, extraction and delivery company, Start Scientific relies on the vast knowledge of its management team, which provides more than half a century of combined industry experience. Leveraging strong industry contacts established by company founder Norris R. Harris, Start Scientific also explores partnership and joint-venture opportunities to further accelerate its growth.
Supported by a management team highly experienced in the workings of natural resources and business development, Start Scientific is well-positioned to achieve its mission to explore low-risk land lease opportunities on properties with known oil deposits, develop facilities on these properties to cost effectively extract the oil, and to distribute the refined oil for sale in the open market. Disclaimer
Start Scientific, Inc. Company Blog
Start Scientific, Inc. News:
Start Scientific, Inc. Signs Farmout Agreement With Durban Energy
Start Scientific, Inc. Acquires Option to Purchase 1,500 Acres of Leases in Matagorda County, Texas
Start Scientific, Inc. Signs Farmout Agreement for Flora Field, Madison County, Mississippi
Well Power Inc. (WPWR)
The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0095, up 11.76%, on 643,699 volume with 14 trades. The stock’s average daily volume over the past 60 days is 289,090, and its 52-week low/high is $0.007/$0.319.
Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.
The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.
Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.
Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer
Well Power Inc. Company Blog
Well Power Inc. News:
Well Power Inc. Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
Well Power - Letter from President to Shareholders
Well Power Inc. to host second webinar on proprietory micro-refinery technology
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0075, up 7.14%, on 9,697,360 volume with 104 trades. The stock’s average daily volume over the past 60 days is 4,353,349, and its 52-week low/high is $0.0008/$0.1786.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
One World Holdings Raises Capital to Fund National Expansion and Convertible Note Elimination
The One World Doll Project to Announce National Retail Store Roll Out of the Prettie Girls! Dolls On April 6 Conference Call
The One World Doll Project CEO Announces 2015 Revenue Projections in Stockholder Letter
Save The World Air, Inc. (ZERO)
The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.43, up 4.80%, on 51,885 volume with 14 trades. The stock’s average daily volume over the past 60 days is 108,391, and its 52-week low/high is $0.3401/$0.889.
Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.
In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.
The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.
STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.
Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer
Save The World Air, Inc. Company Blog
Save The World Air, Inc. News:
STWA Reports 2014 Year-End Financial Results and Provides Operational Update
STWA Sets Date for Its Year-End 2014 Earnings Results Release and Conference Call
STWA Deploys AOT(TM) Viscosity Reduction System on Condensate Pipeline in Eagle Ford
Zenosense, Inc. (ZENO)
The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.2101, up 5.00%, on 32,582 volume with 9 trades. The stock’s average daily volume over the past 60 days is 24,517, and its 52-week low/high is $0.13/$1.00.
Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.
Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.
The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.
Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.
Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer
Zenosense, Inc. Company Blog
Zenosense, Inc. News:
Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial
Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible
Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0485, off by 3.58%, on 1,837,490 volume with 83 trades. The stock’s average daily volume over the past 60 days is 541,133, and its 52-week low/high is $0.0503/$0.1945.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces 2014 Fourth Quarter and Year-End Results
International Stem Cell Corporation Receives Key Stem Cell Patent in Japan
International Stem Cell Corporation Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.32, even for the day. The stock’s average daily volume over the past 60 days is 1,896 and its 52-week low/high is $0.06/$0.45.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
Dominovas Energy Corp. Appoints International Business Professional to Board of Directors
Dominovas Energy and Delphi Sign MOU
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
- Cleartronic, Inc. (CLRI) Adds Shareholder Value With Cancellation of Two Billion Shares of Common Stock Held by CEO
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- eCareer Holdings, Inc. (ECHI) Reports 1000% Increase in Openreq.com Site Traffic, Seeks to Expand Salesforce
- Falcon Crest Energy (FCEN) Acquires Remaining Working Interest in Rocky Ford Field
- IFAN Financial, Inc. (IFAN) Applauds Facebook's Move Into the Mobile Payments Industry, Foresees Ancillary Opportunities
- International Stem Cell Corp. (ISCO) Announces 2014 Fourth Quarter and Year-End Results
- Inventergy Global, Inc. (INVT) Announces $2.15 Million Common Stock Financing to Accelerate Licensing Operations
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International
- One World Holdings, Inc. (OWOO) Raises Capital to Fund National Expansion and Convertible Note Elimination
- Pure Hospitality Solutions, Inc. (PNOW) Pure's Oveedia Signs First Property
- Save The World Air, Inc. (ZERO) Reports 2014 Year-End Financial Results and Provides Operational Update
- Sibling Group Holdings, Inc. (SIBE) Urban Planet Mobile and Rivers Media Group Announce Global Partnership to Deliver Music & Branded Entertainment
- Sparta Commercial Services, Inc. (SRCO) iMobileApp's Customer Base Continues to Diversify
- Start Scientific, Inc. (STSC) Signs Farmout Agreement With Durban Energy
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial